SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-230022
Filing Date
2008-11-07
Accepted
2008-11-07 16:16:26
Documents
9
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 297554
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 18220
3 INVESTOR RIGHTS AGREEMENT DATED JULY 8, 2003 dex43.htm EX-4.3 272175
4 SECOND AMENDMENT TO LEASE DATED JULY 1, 2008 dex101.htm EX-10.1 28925
5 COLLABORATION AGREEMENT DATED JULY 2, 2008 dex102.htm EX-10.2 154432
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8702
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8702
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3349
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3349
  Complete submission text file 0001193125-08-230022.txt   796847
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32405 | Film No.: 081171609
SIC: 2836 Biological Products, (No Diagnostic Substances)